Polaryx Therapeutics, Inc. (PLYX)
3.39
-0.27
(-7.38%)
USD |
NASDAQ |
May 11, 16:00
3.34
-0.05
(-1.47%)
After-Hours: 20:00
Polaryx Therapeutics EPS Diluted (Quarterly) : -0.0316 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.276 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | -2.931 |
| Veru, Inc. | -0.2625 |
| IGC Pharma, Inc. | -0.0076 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.495M |
| Total Expenses (Quarterly) | 1.495M |
| Enterprise Value | 155.35M |
| Earnings Yield | -5.60% |
| Normalized Earnings Yield | -5.091 |